Overall rank by patents
#35,168
of 49,997 tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 15 technology areas, recorded in grant years 2021–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Elyse ranks #35,168 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 15 technology areas.
USPTO PatentsView assignee plate
Corpus R35168 · US Corporation #35,168 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Elika Access Systems, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Elyse Enterprises · this assignee
33 score
3D Lighting… · lowest
7 score
What this shows Elyse's Innovation Score is 32.7/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Elyse Enterprises LLC is a focused PatentsView assignee: 15 CPC subclasses with 57.1% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2022. By volume, Elyse sits between Elika Access Systems, LLC and Emisense Technologies, LLC.
Elyse Enterprises LLC shows 1 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Elika Access Systems, LLC
7 patents
Ellex Medical PTY Ltd
7 patents
Ellis Patents (HOLDINGS) Limited
7 patents
Eloxx Pharmaceuticals Ltd.
7 patents
Embr Labs IP LLC
7 patents
Emefcy Ltd.
7 patents
Emfit OY
7 patents
Emisense Technologies, LLC
7 patents
Elyse Enterprises LLC
7 patents
What this shows Elyse holds 7 patents at rank #35,132, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #35,132 in granted patent volume.
Other assignees with the most granted patents in Elyse's primary technology class.
Elyse's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 42nd percentile higher than 42% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 6 | 85.7% |
| 2022 | 1 | 14.3% |
Top 15 of 15 technology areas
Overall rank by patents
#35,168
of 49,997 tracked assignees
32.7 out of 100
What to do with this data
Elyse Enterprises LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.